Sanofi SA
DUS:SNW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sanofi SA
DUS:SNW
|
FR |
|
D
|
Didim E&F Inc
KOSDAQ:217620
|
KR |
|
Creative Realities Inc
NASDAQ:CREX
|
US |
|
G
|
General Electric Co
BMV:GE
|
US |
|
Amplitech Group Inc
NASDAQ:AMPG
|
US |
|
M
|
MillerKnoll Inc
XMUN:MHR
|
US |
|
Pradiksi Gunatama Tbk PT
IDX:PGUN
|
ID |
|
N
|
Nov Inc
DUS:NO8
|
US |
|
A
|
Avaco Co Ltd
KOSDAQ:083930
|
KR |
|
O
|
Openlane Inc
F:XKR
|
US |
|
Seacoast Banking Corporation of Florida
NASDAQ:SBCF
|
US |
|
Orexo AB
F:C5G
|
SE |
|
Angus Energy PLC
F:A3R
|
UK |
|
La Francaise de l Energie SA
PAR:FDE
|
FR |
|
P
|
Paladin Energy Ltd
F:PUR
|
AU |
|
Gem Diamonds Ltd
LSE:GEMD
|
UK |
|
K
|
Kino Polska TV SA
WSE:KPL
|
PL |
|
A
|
Aptargroup Inc
F:AGT
|
US |
|
Danaher Corp
NYSE:DHR
|
US |
|
A
|
AFP Cuprum SA
SGO:CUPRUM
|
CL |
|
Woolworths Holdings Ltd
F:WN30
|
ZA |
|
ST Group Food Industries Holdings Ltd
SGX:DRX
|
AU |
|
Westpac Banking Corp
ASX:WBC
|
AU |
|
B
|
Bitcoin Group SE
DUS:ADE
|
DE |
Bankruptcy Probability
Sanofi SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sanofi SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Sanofi SA
PAR:SAN
|
100.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
641B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
357.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
207.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
171B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
53.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
390.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
253.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sanofi SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sanofi SA has total debt of 16.3B EUR. This includes both short-term (0 EUR) and long-term (16.3B EUR) debt.
You can find a full breakdown on its Balance Sheet.
